Antagonistic effects of dexamethasone and 1,25-dihydroxyvitamin D3 on the synthesis of nerve growth factor

Area of Science:

• Molecular Endocrinology
• Neuroscience
• Cell Biology

Background:

• Dexamethasone, a glucocorticoid, is known to decrease nerve growth factor (NGF) mRNA levels.
• This inhibitory effect has been observed in various experimental models, including in vivo after sciatic nerve injury.
• Conversely, 1,25-dihydroxy-vitamin D3 (1,25-(OH)2D3) has been shown to promote NGF synthesis in mouse L929 cells.

Purpose of the Study:

• To investigate the combined effects of dexamethasone and 1,25-(OH)2D3 on NGF expression in L929 cells.
• To determine if these steroid hormones can modulate each other's actions on NGF synthesis.
• To explore the potential for hormonal balance to regulate NGF gene expression.

Main Methods:

• Cultured mouse fibroblast-like L929 cells were treated with varying concentrations of dexamethasone and 1,25-(OH)2D3.
• NGF mRNA levels were quantified using molecular assays.
• Secreted mature NGF protein levels were measured through cell-based assays.

Main Results:

• Dexamethasone's inhibitory effect on NGF mRNA and protein was dose-dependently counteracted by 1,25-(OH)2D3.
• The promoting action of 1,25-(OH)2D3 on NGF synthesis was similarly reversed by dexamethasone.
• These findings indicate a reciprocal modulatory relationship between the two steroids.

Conclusions:

• The expression of the nerve growth factor gene is finely tuned by the balance between glucocorticoids and vitamin D.
• In hormone-responsive tissues, 1,25-(OH)2D3 administration may reverse glucocorticoid-induced down-regulation of NGF synthesis.
• This hormonal interplay offers a potential mechanism for regulating NGF levels in physiological and pathological conditions.